medigraphic.com
SPANISH

Revista Cubana de Medicina Militar

ISSN 1561-3046 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 2

<< Back Next >>

Rev Cub Med Mil 2021; 50 (2)

Current knowledge and trends on allergic bronchopulmonary aspergillosis

Ceballos RE, Báez LJM, Figueroa GI, Estruch FIM, Ginard CA
Full text How to cite this article

Language: Spanish
References: 35
Page:
PDF size: 341.79 Kb.


Key words:

aspergillus fumigatus, allergic bronchopulmonary aspergillosis, hypersensitivity.

ABSTRACT

Introduction: Allergic bronchopulmonary aspergillosis is an inflammatory lung disease characterized by a hypersensitivity reaction to colonization of the airway by Aspergillus fumigatus in susceptible individuals, generally patients with asthma and cystic fibrosis.
Objective: To update knowledge in the diagnosis and management of allergic bronchopulmonary aspergillosis.
Development: A thematic, observational and retrospective bibliographic review was carried out, from December / 2019 to July / 2020. Databases such as PubMed/MEDLINE, SciElo, ReserchGate, Scopus, ScienceDirect, Redalyc, Latindex, Wed of Science and LILACS were accessed, using descriptors in Health Sciences (Aspergillus fumigatus, allergic bronchopulmonary aspergillosis, hypersensitivity, allergic bronchopulmonary aspergillosis, allergic bronchopulmonary aspergillose, pulmonary aspergillosis, pulmonary aspergillus, hypersensitivity, hypersensitivity). Articles written in Spanish, English or Portuguese were included, which reported on the subject related to allergic bronchopulmonary aspergillosis, selected by reading the title, the abstract, the full text and by evaluating the variables (types of methodological design, aspects general methodological characteristics of each of the designs found and the quality of the research). With these criteria, 36 national and international articles were selected that included original articles, bibliographic reviews, intervention studies, journals and statistical yearbooks.
Conclusions: Allergic bronchopulmonary aspergillosis is much more frequent than previously assumed, but it is frequently underdiagnosed and the diagnosis is made late, which worsens the prognosis of these patients. Establishing timely diagnosis and treatment will help prevent the development of serious complications.


REFERENCES

  1. Kanj A, Abdallah N, Soubani AO. The spectrum of pulmonary aspergillosis. Resp Med. 2018 [acceso: 2/02/2020];141: 121-31. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/30053957/

  2. Gao Y, Soubani A. Advances in the diagnosis and management of pulmonary aspergillosis. AdvResp Med . 2019 [acceso: 2/02/2020];87(6):231-243 Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31970725/

  3. Duprez M, Soumagne T, Maitre J, Reboux G, Dalphin JC. A case of farmer's lung associated with allergic bronchopulmonary aspergillosis. Rev Mal Resp. 2020 [acceso: 04/02/2020];37(1):80-85. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31870516/

  4. Rajagopal TV, Kant S, Verma SK, Kushwaha RAS, Kumar S, Garg R, et al. Aspergillus sensitization in bronchial asthma: A separate phenotype. Allergy Asthma Proc.2020[acceso: 2/02/2020];41(1):e26-e32. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31888791/

  5. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Diagnosing Allergic Bronchopulmonary Aspergillosis: A Review. Cureus. 2019 [acceso: 12/02/2020];11(4):e4550. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31275774/

  6. Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Treating Allergic Bronchopulmonary Aspergillosis: A Review.Cureus.2019 [acceso: 20/03/2020];11(4):e4538. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31263646/

  7. Sisodia J, Bajaj T. Allergic Bronchopulmonary Aspergillosis. Treasure Isaland: StatPearls; 2020. [acceso: 23/02/2020]. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31194469/

  8. Oguma T, Taniguchi M, Shimoda T, Kamei K, Matsuse H, Hebisawa A, et al. Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey. Allergol Int. 2018 [acceso: 31/01/2020];67(1):79-84. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28546015/

  9. Sehgal IS, Choudhary H, Dhooria S, Aggarwal AN, Bansal S, Garg M, et al. Prevalence of sensitization to Aspergillus flavus in patients with allergic bronchopulmonary aspergillosis. Med. Mycol. 2019 [acceso: 12/03/2020]; 57(3):270-6. Disponible en: Disponible en: https://europepmc.org/article/med/29566248

  10. San Juan Galán JL, Fernández Andreu CM, Martínez Machín G, Perurena Lancha MR, Velar Martínez R. Aspergilosis Pulmonar Crónica. BOLIPK. 2016 [acceso: 09/01/2020]; 26(14):105. Disponible en: Disponible en: https://files.sld.cu/ipk/files/2016/04/bol14-16.pdf

  11. San Juan Galán JL, Fernández Andreu CM, Martínez Machín G, Perurena Lancha MR, Velar Martínez R, Illnait Zaragozí MT. Emergencia en Cuba de especies de aspergillus resistente a antifúngicos. BOLIPK. 2017 [acceso: 13/02/2020]; 27(13): 98 Disponible en: Disponible en: https://www.researchgate.net/publication/316658867_Emergencia_en_cuba_de_especies_de_Aspergillus_resistente_a_antifungicos

  12. San Juan JL, Fernández CM, Almaguer M, Perurena MR, Martínez GF, Velar RE et al. Sensibilidad in vitro de cepas cubanas de Aspergillus spp. de origen clínico y ambiental. Biomédica. 2017 [acceso: 11/04/2020]; 37: 452-9 Disponible en: Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/3447

  13. Gago S, Denning DW, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2019 [acceso: 05/04/2020];57(Supplement_2):S219-S227. Disponible en: Disponible en: https://europepmc.org/article/MED/30239804?singleResult=true

  14. Vitte J, Ranque S, Carsin A, Gomez C, Romain T, Cassagne C, et al. Multivariate Analysis As a Support for Diagnostic Flowcharts inAllergic Bronchopulmonary Aspergillosis : A Proof-of-Concept Study. Front Immunol.2017 [acceso: 12/04/2020]; 8:1019. Disponible en: Disponible en: https://europepmc.org/article/med/28878778

  15. Bhankhur D, Singla N, Aggarwal D, Chander J. Prevalence of allergic bronchopulmonary aspergillosis among patients with severe bronchial asthma in a tertiary care hospital in Northern India. Indian J Pathol Microbiol. 2019 [acceso: 20/02/2020];62(1):111-113. DOI: 10.4103/ijpm.ijpm_205_18

  16. Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert RevResp Med . 2016 [acceso: 3/03/2020];10(12):1317-1334. Disponible en: Disponible en: https://www.researchgate.net/publication/309214089_Developments_in_the_diagnosis_and_treatment_of_allergic_bronchopulmonary_aspergillosis

  17. Maleki M, Mortezaee V, Hassanzad M, Mahdaviani SA, Poorabdollah M, Mehrian P, et al. Prevalence of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Patients using Two Different Diagnostic Criteria.Eur Ann Allergy ClinImmunol. 2019 [acceso: 3/02/2020]; 52(3):104-111 Disponible en: Disponible en: https://europepmc.org/article/med/31702121

  18. Beltrán Rodríguez N, San Juan-Galán JL, Fernández Andreu CM, Yera DM, Barrios Pita M, Perurena Lancha MR, et al. Chronic Pulmonary Aspergillosis in Patients with Underlying Respiratory Disorders in Cuba-A Pilot Study. J fungi. 2019 [acceso: 20/07/2020]; 5(18):[aprox9 pant]. DOI: 10.3390/jof5010018

  19. Ministerio de Salud Pública de Cuba. Anuario estadístico de salud 2019. La Habana: MINSAP; 2020. [acceso: 28/04/2020]. Disponible en: Disponible en: https://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  20. WHO. Global tuberculosis report 2019. Geneva: World Health Organization; 2019. [acceso: 30/06/2020]. Disponible en: Disponible en: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf

  21. Greenberger PA, Smith LJ, Hsu CC, Roberts M, Liotta JL. Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE. J. Allergy Clin. Immunol. 1988 [acceso: 3/03/2020];82(2):164-70. Disponible en: Disponible en: https://europepmc.org/article/med/3042837

  22. Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koëter GK. Review of fungus-induced asthmatic reactions. Am J. Respir Crit Care Med. 1995 [acceso: 25/02/2020];151(6):2109-15 Disponible en: Disponible en: https://europepmc.org/article/med/7767565

  23. Patel G, Greenberger PA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc. 2019 [acceso: 2/03/2020];40(6):421-424. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31194469/

  24. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc. 2001 [acceso: 30/01/2020];76(9):930-8. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0025619611621149

  25. Tetikkurt C, Kubat B, Tetikkurt S, Karakas G. An atypical acute exacerbation of COPD due to Aspergillus fumigatus. Monaldi Arch Chest Dis. 2020 [acceso:12/03/2020]; 90(1):[aprox4 pant]. Disponible en: Disponible en: https://www.monaldi-archives.org/index.php/macd/article/view/1155

  26. Peccini L, Pennoni S, Mencarini V, Saponara M, Palladino N, Principi N, et al. A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus. Pathogens. 2019 [acceso: 20/01/2020];9(1):15. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31877884/

  27. Zhang C, Jiang Z, Shao C. Clinical characteristics of allergic bronchopulmonary aspergillosis. Clin Resp J. 2020 [acceso: 3/03/2020];14(5):440-446 Disponible en: Disponible en: https://europepmc.org/article/med/31901186

  28. Moghtaderi M, Farjadian S, Hossieni Teshnizi S, Hadibarhaghtalab M. Allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization in patients with uncontrolled asthma: An experience from Southwestern Iran. Med J Islam RepubIran. 2019 [acceso: 2/02/2020];33:95. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31696089/

  29. Michel M, Gomez C, Sereme Y, Gouitaa M, Chartier C, Blanchard P, et al. Evaluation of Cellular Responses for the Diagnosis of Allergic Bronchopulmonary Mycosis: A Preliminary Study in Cystic Fibrosis Patients. Front Immunol . 2020 [acceso: 12/05/2020]; 10:3149. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32117206/

  30. Shah A, Panjabi C. Allergic Bronchopulmonary Aspergillosis : A Perplexing Clinical Entity. Allergy Asthma Immunol Res. 2016 [acceso: 12/01/2020];8(4):282-97. Disponible en: Disponible en: https://synapse.koreamed.org/search.php?where=aview&id=10.4168/aair.2016.8.4.282&code=0166AAIR&vmode=FULL

  31. Ayoubi N, Jalali S, Kapadia N. A Case of Allergic Bronchopulmonary Aspergillosis (ABPA) in a Patient with a History of Cocaine Use and Tuberculosis. Case Rep Med. 2019 [acceso: 3/02/2020]; 2019: 3265635Disponible en: Disponible en: https://www.hindawi.com/journals/crim/2019/3265635/

  32. Suri T, Makkar N, Ray A, Sood R.A unique case of hydropneumothorax in allergic bronchopulmonary aspergillosis. Med Mycol Case Rep. 2019 [acceso: 12/02/2020]; 25:29-31. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31338287/

  33. Gothe F, Schmautz A, Häusler K, Tran NB, Kappler M, Griese M. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis. J Allergy Clin Immunol Pract. 2020 [acceso: 20/03/2020]; 8(8):2608-2614.e3. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2213219820301926

  34. Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012 [acceso: 22/02/2020];49(4):423-33. Disponible en: Disponible en: https://www.tandfonline.com/doi/abs/10.3109/02770903.2012.662568?journalCode=ijas20

  35. Lanternier F, Seidel D, Pagano L, Styczynski J, Mikulska M, Pulcini C, et al. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey. Mycoses. 2020 [acceso: 31/01/2020]; 63(5):420-429. Disponible en: Disponible en: https://moh-it.pure.elsevier.com/en/publications/invasive-pulmonary-aspergillosis-treatment-duration-in-haematolog




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Med Mil . 2021;50